12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Other News

Medicines Co. cardiovascular news

The Medicines Co. and law firm Wilmer Cutler Pickering Hale and Dorr LLP reached a settlement agreement related to the patent term extension for anticoagulant Angiomax bivalirudin. The company will receive $18 million up front, and is eligible for...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >